Trial Profile
Effect of ibrutinib in patients with relapsed chronic lymphocytic leukemia after allogeneic transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2015
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 07 Apr 2015 New trial record